<DOC>
	<DOC>NCT02048683</DOC>
	<brief_summary>Comparing a pharmacokinetic model of a short sevoflurane sedation in burn ICU patients with control ICU patients.</brief_summary>
	<brief_title>A Pharmacokinetic Study of Sevoflurane Inhalation in Burn ICU Patients</brief_title>
	<detailed_description>Prospective clinical study in ICU with sedated ventilated patients with sevoflurane with the AnaCondaÂ® system, establishing pharmacokinetic model of sevoflurane and its metabolites (hydroxyfluroisopropanol, fluoride) comparing burn and non burn ICU patients</detailed_description>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Adult patients ventilated requiring invasive procedure in ICU Stable respiratory and hemodynamic conditions Consent of patients or family Arterial line Burn patients : burn area between 20 and 50% (3rd degree) OR non burn patients BMI &lt;30 Sevoflurane anaphylaxia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Sevoflurane</keyword>
	<keyword>Burn</keyword>
	<keyword>Sedation</keyword>
</DOC>